WPL06866 - Donor Search and Provision Service

Location

Southampton

Description

This contract is for the provision of stem cell services to support the UHS Transplant Centre. The four core services are: - Manages adult volunteer donors and cord blood banks to source and distribute stem cells and lymphocytes. - Coordinates international donor searches and manages the import/export of therapeutic cells. - Conducts tissue-typing tests and advises on matching the best graft for patients. - Sources and distributes cells from related family donors.

Total Quantity or Scope

The provider is to continue providing registry services, donor typing, matching, and stem cell procurement and distribution. This contract award has been made following the PSR Direct Award Process A. The maximum amount payable under this contract between the dates shown below is £5,500,000 excluding VAT. Contract Start: 01/06/2026 Contract End: 31/05/2029

Award Detail

Award Criteria

CPV Codes

• 85146200 - Services provided by transplant organ banks

Indicators

• Award on basis of price and quality.

Legal Justification

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

Other Information

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The decision makers: Trust Clinical and Commercial & Procurement support functions. A Trust employee involved in drafting the service level agreement declared a professional connection with the provider through the conflicts assessment process. To mitigate any perceived risk, this individual was completely excluded from the supplier validation and contract approval chain. Independent clinical and commercial stakeholders subsequently conducted an un-conflicted review of the contract to ensure appropriate governance and value for money.